Quantcast
Browsing all 2570 articles
Browse latest View live

New JAMA study supports 2013 guidelines on statin therapy for patients at...

New data published in the Journal of the American Medical Association JAMA supports 2013 guidelines

View Article


Global Statin Market 20152019

Recently added to the BioPortfolio report storeGlobal Statin Market 20152019 is a new report fromTechnavio published on 20150707.This 81page reportis available in pdffrom $2500.About Statin Statin is a...

View Article


Two JAMA studies justify increased use of statins

Michael JohnsenThe new guidelines have been expected to increase the number of statineligible adults by almost 13 million.read more

View Article

FH Common Undertreated in ACS Patients

The estimates of FH in ACS are three to six times higher than in the general population according to a registry report and these highrisk patients remained undertreated with statin therapy. Heartwire...

View Article

Broader Statin Use Shown To Be Cost Effective And Save Lives. Will This...

Statins are remarkable drugs in the war against heart disease the worlds leading killer. Its time to incorporate them more broadly in healthcare.

View Article


StatinAssociated Muscle Symptoms Impact on Statin Therapy

Statinassociated muscle symptoms are one of the principal reasons for statin nonadherence. What's the plan when patients don't tolerate statins European Heart Journal

View Article

Drug Discovery Spotlight Studies Support Broader Statin Use; HCV Meds...

Two years ago cardiology organizations issued guidelines recommending use of a tool to assess patients risk of heart attack or stroke. The new method came under scrutiny but this week two published...

View Article

Statin Cost Effectiveness Underscored In JAMA Study

Study by researchers at Harvard analyzes the costeffectiveness of statins in patients at low risk of cardiovascular disease under current cholesterol guidelines.

View Article


Are metformin statin and aspirin use still associated with overall mortality...

View Article


Statin Overuse Risky Warns Association of American Physicians and Surgeons AAPS

TUCSON Ariz. July 20 2015 GLOBE NEWSWIRE Two studies published in the July 14 issue of JAMA support new guidelines that could nearly double the number of Americans taking statin drugs to prevent...

View Article

Dr. Nathan D. Wong to Deliver Opening Lecture at International Academy of...

Asher Kimchi M.D. Founder and Chairman of the International Academy of Cardiology today announced the selection of Nathan D. Wong Ph.D. MPH Professor and Director Heart Disease Prevention Program...

View Article

Use of controversial ACCAHA guidelines for statin therapy is supported by US...

Controversial guidelines for lipid lowering statin therapy issued by the American College of Cardiology ACC and the American Heart Association AHA in 2013 do a better job of identifying people at...

View Article

European Commission Approves Amgen's New CholesterolLowering Medication...

THOUSAND OAKS Calif. July 21 2015 PRNewswire &160;Amgen NASDAQAMGN today announced that the European Commission EC has granted marketing authorization for Repatha&8482; evolocumab the first...

View Article


EU Approves PCSK9 Inhibitor Evolocumab Repatha

As the first PCSK9 inhibitor to make it to market evolocumab is approved in a wide array of patients including the statin intolerant and those unable to get to goal with maximally tolerated statin....

View Article

New study 80 of people with established cardiovascular disease significantly...

ST. PAUL Minn. July 21 2015 PRNewswire &160;The first of two cholesterollowering PCSK9 inhibitors Proprotein Convertase SubtilisinKexin type 9 is expected to be approved by the U.S. Food and Drug...

View Article


EU approves Amgen's PCSK9 inhibitor

Amgen Inc. NASDAQAMGN said the European Commission approved an MAA for Repatha evolocumab to treat several groups of patients with high cholesterol. The approval is the first anywhere for a PCSK9...

View Article

Prime suggests limited PCSK9 coverage

Pharmacy benefit manager Prime Therapeutics LLC Eagan Minn. suggested Tuesday it may limit access to PCSK9 inhibitors to patients with familial hypercholesterolemia based on an analysis of its claims...

View Article


Europe first with approval of Amgens cholesterol drug Repatha

Amgen's cholesterol drug Repatha has been given the green light in Europe making it the first in the new PCSK9 inhibitor class approved anywhere in the world.Repatha evolocumab is a human monoclonal...

View Article

EC approves Amgen's PCSK9 inhibitor

Amgen Inc. NASDAQAMGN said the European Commission approved an MAA for Repatha evolocumab to treat several groups of patients with high cholesterol. The approval is the first anywhere for a PCSK9...

View Article

Penn study finds link between physician training and brand name prescribing

University of Pennsylvania School of Medicine Physicians in training are twice as likely to order a costly brandname statin used to lower blood cholesterol levels when supervised by senior physicians...

View Article
Browsing all 2570 articles
Browse latest View live